| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 59.782 | 82.994 | 84.139 | 88.039 |
| Total Income - EUR | - | - | - | - | - | - | 59.973 | 83.568 | 84.200 | 88.048 |
| Total Expenses - EUR | - | - | - | - | - | - | 2.055 | 2.978 | 10.342 | 11.531 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 57.917 | 80.590 | 73.857 | 76.516 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 56.155 | 78.718 | 73.058 | 74.739 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Clinical Research Consulting S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 106 | 295 | 0 | 1.886 |
| Current Assets | - | - | - | - | - | - | 75.595 | 99.382 | 93.566 | 94.405 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 60.945 | 85.620 | 80.460 | 83.254 |
| Cash | - | - | - | - | - | - | 14.650 | 13.763 | 13.106 | 11.150 |
| Shareholders Funds | - | - | - | - | - | - | 56.195 | 78.767 | 73.106 | 74.788 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 19.505 | 20.911 | 20.460 | 21.503 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Clinical Research Consulting S.r.l.